ACE2-Fc exhibited a dose-dependent inhibition of infection across a wide range of pseudoviruses, spanning from the WT to the XBB.1 variant, with effective concentrations ranging from 6.4 to 50 μg/ml (Fig. 2B). The gene discussed is ACE2; the disease is infection.